Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial

Mwayiwawo Madanitsa(Malawi University of Science and Technology), Feiko O. ter Kuile(Kenya Medical Research Institute), Nigel Klein(Great Ormond Street Hospital), Daniel T. R. Minja(National Institute for Medical Research), Julie Gutman(Centers for Disease Control and Prevention), Jacklin F Mosha(National Institute for Medical Research), Victor Mwapasa(Kamuzu Central Hospital), Pascal Magnussen(Capital Region of Denmark), James Dodd(North Bristol NHS Trust), Simon Kariuki(Kamuzu Central Hospital), Duolao Wang(Guangdong Medical College), Samwel Gesase(National Institute for Medical Research), Queen Saidi(Kilimanjaro Christian Medical Centre), Crispin Mukerebe(National Institute for Medical Research), Eric D Onyango(Kenya Medical Research Institute), Reginald A. Kavishe(Kilimanjaro Christian Medical Centre), Helle Hansson(University of Copenhagen), Kamija S. Phiri(Liverpool School of Tropical Medicine), R Matthew Chico(London School of Hygiene & Tropical Medicine), Omari Abdul Msemo(National Institute for Medical Research), Michael Alifrangis(University of Copenhagen), John Lusingu(National Institute for Medical Research), George Mtove(National Institute for Medical Research), Hellen C. Barsosio(Liverpool School of Tropical Medicine), Christentze Schmiegelow(Copenhagen University Hospital), Kephas Otieno(Kenya Medical Research Institute), Kenneth Maleta(University of Malawi)
The Lancet
March 1, 2023
Cited by 72


Related Papers